We are live on ! Find out more
KURA icon

Kura Oncology
KURA

148 hedge funds and large institutions have $795M invested in Kura Oncology in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 42 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

373% more call options, than puts

Call options by funds: $7.02M | Put options by funds: $1.48M

32% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 22

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

19% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 42

5% more funds holding

Funds holding: 141 → 148 (+7)

4.45% less ownership

Funds ownership: 105.86% → 101.41% (-4.5%)

10% less capital invested

Capital invested by funds: $885M → $795M (-$90.2M)

Holders
148
Holders Change
+7
Holders Change %
+4.96%
% of All Funds
2.32%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
29
Increased
50
Reduced
42
Closed
22
Calls
$7.02M
Puts
$1.48M
Net Calls
+$5.54M
Net Calls Change
+$5.68M

Top Buyers

1
PM
Prosight Management
Texas
+$15.9M
2
PBA
Paradigm Biocapital Advisors
New York
+$11.9M
3
AC
Armistice Capital
New York
+$10.5M
4
DM
Deerfield Management
New York
+$10.1M
5
BlackRock
BlackRock
New York
+$9.32M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$30M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$14M
3
EC
EcoR1 Capital
California
-$9.83M
4
State Street
State Street
Massachusetts
-$9.81M
5
SI
Sofinnova Investments
California
-$7.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Suvretta Capital Management
New York
$74.4M +$5.38M +455,107 +7%
BI
2
BVF Inc
California
$71.2M – – –
BlackRock
3
BlackRock
New York
$65.1M +$9.32M +788,095 +15%
EC
4
EcoR1 Capital
California
$61.4M -$9.83M -831,500 -13%
Vanguard Group
5
Vanguard Group
Pennsylvania
$38.6M +$1.96M +166,055 +5%
DM
6
Deerfield Management
New York
$34.3M +$10.1M +855,000 +36%
ACA
7
Avoro Capital Advisors
New York
$32.9M – – –
State Street
8
State Street
Massachusetts
$31.9M -$9.81M -829,530 -22%
Holocene Advisors
9
Holocene Advisors
New York
$25.8M – – –
AC
10
Armistice Capital
New York
$22.5M +$10.5M +888,000 +72%
AG
11
Artal Group
Luxembourg
$21.4M +$3.55M +300,000 +17%
Citadel Advisors
12
Citadel Advisors
Florida
$20.3M -$225K -18,992 -1%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$20.2M +$906K +76,572 +4%
FCMI
14
Foresite Capital Management IV
California
$19.6M – – –
TCM
15
TCG Crossover Management
California
$15.1M – – –
CC
16
Commodore Capital
New York
$14.8M +$2.31M +195,042 +16%
PM
17
Prosight Management
Texas
$14.2M +$15.9M +1,343,359 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$14.1M +$492K +41,576 +3%
Franklin Resources
19
Franklin Resources
California
$13M +$388K +32,821 +3%
Assenagon Asset Management
20
Assenagon Asset Management
Luxembourg
$12.2M – – –
PBA
21
Paradigm Biocapital Advisors
New York
$10.6M +$11.9M +1,004,908 New
Goldman Sachs
22
Goldman Sachs
New York
$9.84M -$1.85M -156,442 -14%
AAA
23
Affinity Asset Advisors
New York
$9.63M +$6.54M +553,030 +155%
Bank of America
24
Bank of America
North Carolina
$9.54M +$4.67M +395,044 +78%
WP
25
Woodline Partners
California
$9.17M +$4.47M +377,530 +77%
1
2 3 4 5

KURA Hedge Fund Activity: Q2 2023 in Review

148 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2023, worth a combined $795M — down 10% from $885M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new KURA positions and 22 closed out — a net gain of 7 holders — while 50 added to existing stakes and 42 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $15.9M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $30M sold.

  • 148 institutional investors held Kura Oncology (KURA) as of Q2 2023, up from 141 in Q1 2023.
  • Funds reported $795M of Kura Oncology stock for Q2 2023, down 10% quarter-over-quarter.
  • 29 funds opened new Kura Oncology positions in Q2 2023 and 22 closed out, a net change of +7 holders.
  • The largest Kura Oncology buyer in Q2 2023 was Prosight Management, an estimated $15.9M added.
  • The largest Kura Oncology seller in Q2 2023 was T. Rowe Price Investment Management, an estimated $30M sold.

Based on aggregated 13F filings for Q2 2023.